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tion [9-13]. Microinjection of CHOP protein into NIH3T3 Abstract CHOP (GADD153) is a member of the C/EBP 
family and a stress-induced protein. To investigate the role of cells induces G1/S arrest of the cell cycle [14,15]. This requires 
CHOP in cellular growth, we expressed CHOP conditionally in both a leucine zipper domain and a basic region. In myxoid 
M1 myeloblastic leukemia cells that do not express p53 protein, liposarcoma, a tumor of human adipose tissue, a t(12;16) 
More than 60% nf M1 cells died through apoptosis 72 h after chromosomal translocation results in the expression of an 
CHOP induction. Site-directed mutagenesis revealed that this oncogenic fusion protein between CHOP and the amino ter- 
process requires leucine zipper domain but neither intact basic minus of a RNA binding protein, TLS or FUS [16,17]. These 
region nor trans-activation domain. CHOP-mediated apoptosis studies suggest hat CHOP may play a role in an inducible 
accompanied ownregulation of bcl-2 mRNA and overexpression growth arrest pathway that is triggered by DNA damage or 
nf Bcl-2 delayed the process. Our results indicate that CHOP metabolic stress. 
can induce apoptosis in a p53-independent manner. Murine M1 myeloblastic leukemia cells undergo apoptosis 
Key words." CHOP; GADD153; Apoptosis; p53; Leucine following exposure of genotoxic stresses such as methyl 
zipper; Bcl-2 methanesulfonate and ultraviolet irradiation [18]. IL-6 or 
LIF also induces terminal differentiation and growth arrest 
of M1 cells, ultimately culminating in apoptosis [18]. In 
both cases the dramatic induction of CHOP mRNA coincided 
1. Introduction with the induction of apoptosis. It is well known that p53 
plays a pivotal role in DNA damage-inducible growth arrest 
CHOP (,C/EBP-homologous protein), also known as and apoptosis [19]. However, M1 cells do not express p53 
GADDI53, is a member of the C/EBP family, a group of protein [20], indicating that apoptosis of M1 cells cannot be 
leucine zipper proteins that share extensive amino acid homol- mediated by the p53-dependent pathway. This finding sug- 
ogy with the DNA binding domain of C/EBP. The family gests that CHOP may mediate growth arrest and apoptosis 
currently consists of six members including C/EBP (C/ in M1 cells by a p53-independent pa hway. To investigate he 
EBPc~), NF-IL6 (C/EBPI3), Ig/EBP (C/EBPT), NF-IL6I~ (C/ role of CHOP in M1 cells, we took advantage of the inducible 
EBPS), CRP1, and CHOP [1-8]. These members can form expression system by which CHOP protein can be expressed 
homo- and heterodimers, all of which recognize the same conditionally by adding isopropyl [3-D-thiogalactoside (IPTG). 
nucleotide sequences except for CHOP. CHOP can form di- The present study demonstrates that conditional expression of 
mers with other family members, but the heterodimers cannot CHOP protein is able to induce apoptosis in M1 cells. 
bind to the C/EBP binding consensus because of several ami- 
no acid substitutions in the DNA binding domain. This find- 2. Materials and methods 
ing suggests that CHOP may act as a negative modulator of 
the activity of other C/EBP family members [8]. CHOP is 2.1. Cells and cell culture 
expressed at undetectable levels in growing mammalian cells Murine M1 myeloblastic leukemia cells were cultured in Eagle's 
but is markedly increased by treatment with genotoxic agents, minimal essential medium and 10% fetal calf serum. The presented 
data were obtained using the M1Mock clone 3, MlwtCHOP clone 19, 
calcium ionophore, lipopolysaccharide, and nutrient depriva- M1L133A/L140A clone 2, M1A105-115 clone 18, M1A1-88 clone 10, 
M1CHOP/puro clone 11, M1CHOP/Bcl-2 clone 18; however, for each 
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Fig. 1. IPTG-induced expression of CHOP triggers apoptosis in M1 cells. A: Establishment of M1CHOP derivative clones. The indicated 
clones were either treated (+) or untreated ( - )  with 5 mM IPTG for 8 h and subjected to Western blot analysis. B: Viability of MICHOP de- 
rivative cells treated with IPTG. Viability was determined at 0, 24, 48 and 72 h time points by trypan blue exclusion. Each value represents he 
mean of three independent experiments. The error bars represent s andard eviation. C: Induction of DNA fragmentation in M1CHOP deriva- 
tive cells. The indicated clones were either treated (+) or untreated ( - )  with IPTG for 72 h and harvested for DNA extraction. Genomic DNA 
(5 ~tg/lane) was electrophoresed on a 2% agarose gel and visualized under UV light. D: Visualization of apoptotic ells by Hoechst staining. 
MlwtCHOP cells were cultured with (+) or without ( - )  IPTG for 72 h, fixed in glutaraldehyde, stained with Hoechst 33258 and observed un- 
der fluorescent microscopy. Magnification: X 200. 
Kodak) epitope, respectively. The upstream primer sequences were 5'- follows: L 133A/L 140A, 5'-AAAGTGGCTCAGGCAGCTGAGGA- 
GGTCGACCACCATGGCAGCTGAGTCCCTG-3' (for pOPRSVI- GAACGAGCGGGCCAAGCAGGAAATCGAG-3'; A105-115, 5'- 
wtCHOPFlag) and 5'-GGTCGACCACCATGGCTCAGGAGGAA- CGAACCAGGAAACGGAAAAAGCAGCGCATGAAGGAG-3'. 
GAG-3' (for pOPRSVI-A1-88CHOPFIag). The common downstream 
primer sequence was 5'-CGTCGACTCACTTGTCATCGTCGTCC- 2.3. Stable transfections 
TTGTAGTCTACTTGTTGCAGATTTAC-3'. After cloned into To prepare doubly transfected clones, 107 exponentially growing 
pT7Blue-T vector (Novagen), these PCR-amplified products were ver- M1 cells were cotransfected via electroporation with 20 I.tg of P3'SS 
ified by automated DNA sequencing utilizing dye-labeled dideoxynu- lac repressor-expressing vector and 20 ~tg of pOPRSVI-CHOPFIag 
cleotides. Following digestion, each fragment was cloned into pOPRS- derivative. Cells were placed in growth medium for 24 h, then trans- 
VI operator vector. Wild-type CHOPFlag fragment was also inserted ferred to 24-well plates, and placed under selection with 75 I.tg of 
into PUC19 vector and then this vector was used to generate LI33A/ hygromycin B (Boehringer) and 400 I.tg of geneticin (BRL) per ml 
L140ACHOPFlag and A105-115 CHOPFlag. The sequences of the for 14 days. Single colonies were expanded and tested for expression 
oligonucleotides u ed to generate the mutation and deletion are as of CHOPFlag derivative by Western blot analysis after 8 h treatment 
M. Matsumoto et al.IFEBS Letters 395 (1996) 143-147 145 
with IPTG. To generate CHOP/Bcl-2 or CHOP/puro cell lines, 
MlwtCHOP-19 cells were cotransfected with 20 gg of PSVT-B [21] Mock  wtCHOP 
and 1 lag MSCV pac, selected under 5 lag/ml puromycin (Sigma), and 
expanded as described above. MSCV pac was employed for expres- 0 24  48  72  0 24 48  72  h 
sion of the puromycin resistance gene. 
2.4. DNAfragmentationassay ........ 
Genomic DNA was extracted by using SepaGene (Sanko Junyaku). bel-2 ~ ~ 
Following treatment with RNase A (20 Ixg/ml) for 1 h, DNA was . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
precipitated with polyethylene glycol and the purified DNA (5 lag/ i ~ ~  
lane) was fractionated on a 2% agarose gel with TAE (40 mM Tris- bax  
acetate, 1mM EDTA) as the running buffer. The electrophoresed gel 
was stained with ethidium bromide (0.5 lag/ml) and visualized under ..... 
UV light. 
2.5. Hoechst staining e-mye 
MlwtCHOP cells were cultured with or without 5 mM IPTG for 72 
h, fixed in glutaraldehyde (1% in PBS), stained with Hoechst 33258 (1 
mM in PBS, Sigma), and observed under fluorescent microscopy, c-myb ii 
2.6. Western blot analysis 
To detect CHOPFlag derivative protein, cells were lysed directly in GAPDH 
1 ×Laemmli buffer. After boiling for 5 min, cell lysates (2x 105 cells 
per lane) were separated by SDS-PAGE (15-25% gradient polyacryl- 
amide), electrophoretically transferred to nitrocellulose membranes, . . . . . . . . .  
and then analyzed for immunoreactivity with a monoclonal ntibody 
specific for the FLAG-epitope tag (M2, Kodak) by the enhanced Fig. 2. Effect of conditional expression of CHOP on apoptosis- and 
chemiluminescence det ction system (Amersham). growth-related genes. M1Mock and MlwtCHOP cells were stimu- 
lated with IPTG (5 mM) and total RNA (20 p.g/lane) prepared at 
2.7. Northern blot analysis the indicated times was analyzed by Northern blot hybridization 
Cytoplasmic RNA was obtained by a guanidine isothiocyanate-ce- with the indicated cDNA probes. 
sium chloride gradient centrifugation method [22]. Total RNA (20 lag/ 
lane) was separated on a 1.0% agarose gel containing 6.0% formalde- 
hyde. After transfer to a Hybond N + nylon membrane (Amersham) in
10xSSC (1XSSC is 0.15 M NaC1 plus 0.015 M sodium citrate), rein, A1-88 protein level was extremely lower than other 
hybridization and wash were performed according to the method of 
Church and Gilbert [23], using cDNA probes labeled by the random CHOP derivatives. Expression of CHOP derivative proteins 
primer method. The probes for bcl-2 and bax were RT-PCR products reached at a maximum level within 4 h after IPTG addition 
prepared from M1 cells as follows: bcl-2, nucleotides 1892-2433; bax, and lasted for more than 72 h (data not shown). Following 
nucleotides 35-579. The probes for c-myc, c-myb and glyceraldehyde- treatment with IPTG, viability of M1CHOP derivative cells 
3-phosphate dehydrogenase (GAPDH) were the same as used pre- 
viously [24]. CHOP probe was the complete coding cDNA fragment was determined. As shown in Fig. 1B, the viability of 
of hamster CHOP. Human bcl-2 probe was the 0.95Kb XhoI fragment wtCHOP and A105-115 cells began to decrease 48 h after 
from PSVT-B. addition of IPTG. By 72 h, more than 60% of wtCHOP 
and A105-115 cells died, whereas more than 90% of Mock 
3. Results and discussion and L133A/L140A cells survived (Fig. 1B). Although A1-88 
cells did not lose viability for up to 48 h, its viability dropped 
3.1. IPTG-induced expression o f  CHOP triggers apoptosis in to about 60% during next 24 h. The late decrease of viability 
M1 cells by A1-88 cells was considered to be due to low expression 
Attempts to establish M1 cell lines that constitutively ex- level of its proteins. Then we examined, by gel electrophoresis, 
press high levels of CHOP protein have been unsuccessful genomic DNA from M1CHOP derivative cells after treatment 
probably due to the antimitotic activity of this protein. To with IPTG. The characteristic 'ladder' pattern of DNA (Fig. 
circumvent this problem, we developed clonal derivatives of 1C) was observed 72 h after IPTG addition to M1CHOP 
M1 cells which contain the hamster CHOP gene under control derivative cells except L133A/L140A cells. Hoechst staining 
of the lac repressor. Mock clones expressing lac repressor and of wtCHOP cells revealed nuclear morphological features as- 
pOPRSVI vector without an insert were selected as negative sociated with apoptosis including condensed nuclei and frag- 
controls. Moreover, three CHOP derivatives were constructed mented chromatin (Fig. 1D). These studies indicated that 
to define the functional domain of CHOP protein. The first IPTG-treated M1CHOP derivative cells except L133A/ 
derivative, L133A/L140A, lacks the functional leucine zipper L140A cells died through apoptosis and CHOP-mediated 
domain in which two of three leucines composing leucine apoptosis requires leucine zipper domain but neither intact 
zipper are substituted by alanines. The second derivative, basic region nor trans-activation domain of CHOP protein. 
A105-115, lacks the central portion of the basic region corre- On the other hand, CHOP-mediated growth arrest and onco- 
sponding to DNA binding domain in other C/EBPs. The third genic transformation by TLS-CHOP require an intact basic 
derivative, A1-88, lacks a large portion of the trans-activation region, suggesting that DNA binding by CHOP may be im- 
domain. At the same time, FLAG-epitope was tagged to the plicated in these activities [14,15]. Recently, it was demon- 
C-terminus of each CHOP derivative protein in order to dis- strated that CHOP-C/EBP and CHOP-NF-IL6 dimers bind 
criminate the endogenous one. Stable expression of CHOP to unique DNA control elements different from C/EBP con- 
derivative proteins were driven by addition of IPTG in M1 sensus and activate unknown genes [25]. This transcriptional 
cells (Fig. 1A). While 133A/140A and A105-115 proteins were activity requires the intact basic region of CHOP protein. 
expressed at comparable l vels to wild-type (wt) CHOP pro- However, CHOP-mediated apoptosis does not require an in- 
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Fig. 3. Effect of ectopic expression of Bcl-2 on CHOP-mediated apoptosis n M1 cells. A: Establishment of M1CHOP/puro and M1CHOP/Bcl- 
2 clones. Expression of the human bcl-2 and CHOP transgenes in M1CHOP/puro and M1CHOP/Bcl-2 cells were analyzed by Northern blot 
hybridization. B: Viability of M1CHOP/puro and M1CHOP/Bcl-2 cells treated with IPTG. M1CHOP/puro and M1CHOP/Bcl-2 cells were 
treated with (+) or without (-) IPTG (5 mM). Viability was determined at0, 24, 48 and 72 h time points after addition of IPTG by trypan 
blue exclusion. Each value represents the mean of three independent experiments. The error bars represent s andard eviation. 
tact basic region. This finding suggests that the mechanisms ment with IPTG. M1CHOP/puro clones expressing only puro- 
underlying CHOP-mediated growth arrest shown in previous mycin resistance gene were also isolated as controls. 
reports [14,15] and apoptosis in this study are quite different. M1CHOP/puro and M1CHOP/Bcl-2 clones expressed similar 
In the case of CHOP-mediated growth arrest, CHOP may levels of CHOP following stimulation with IPTG (Fig. 3A). 
activate the transcription of several genes and cause cell cycle While CHOP/puro cells lost viability in a similar kinetics to 
arrest, while in the case of CHOP-mediated apoptosis, CHOP wtCHOP cells, CHOP/Bcl-2 cells did not die until 48 h fol- 
may act as a dominant negative inhibitor of other transcrip- lowing addition of IPTG (Fig. 3B). However, the viability of 
tion factors and repress the expression of those target genes CHOP/Bcl-2 cells was decreased to about 75% at 72 h after 
which is essential for cell survival, addition of IPTG. These results establish that high levels of 
Bcl-2 effectively delay but do not completely block CHOP- 
3.2. Bcl-2 mRNA reduction precedes CHOP-mediated mediated apoptosis in M1 cells. This finding may suggest 
apoptosis the presence of some other genes for cell survival which are 
We examined the effect of CHOP proteins on the expression negatively regulated by CHOP protein, besides bcl-2. 
of apoptosis- and growth-related genes (Fig. 2). Bcl-2, which In conclusion, we have demonstrated that CHOP induces 
promotes cell survival, and Bax, which promotes cells death, apoptosis in M1 myeloblastic leukemia cells in p53-independ- 
have been implicated as major players in the control of apop- ent manner and Bcl-2 delayed this process, p53 is the most 
totic pathways [26]. As shown in Fig. 2, bcl-2 mRNA reduc- commonly mutated gene in human cancer [30], and cells lack- 
tion preceded wtCHOP-mediated cell death, but bax mRNA ing intact p53 protein are resistant to killing by radiation and 
levels remained unaltered uring progression of apoptosis, chemotherapy [31]. To understand the mechanism underlying 
Other clones expressing M1CHOP derivatives except L133A/ CHOP-mediated apoptosis in M1 cells may provide a novel 
L140A also showed downregulation f bcl-2 mRNA prior to therapeutic strategy against p53-inactivated malignancies. 
cell death (data not shown). Decrease in the ratio of bcl-2 to 
bax may be in part responsible for CHOP-mediated apoptosis Acknowledgements: We thank A.J. Fornace Jr. for providing the 
as described in p53- or TGF-~l-induced apoptosis [27,28]. hamster CHOP (GADD153) eDNA, T. Miyazaki for providing the 
human Bcl-2 expression vector, and K. Kubota for secretarial ssist- 
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